Revelation Biosciences Inc Share Price Today: Live Updates & Key Insights

Revelation Biosciences Inc share price today is $1.23, up -0.83%. The stock opened at $1.205 against the previous close of $1.2, with an intraday high of $1.21 and low of $1.205.

Revelation Biosciences Inc Share Price Chart

Revelation Biosciences Inc

us-stock
To Invest in {{usstockname}}
us-stock

Revelation Biosciences Inc Share Price Performance

$1.23 -0.0083(-0.83%) REVB at 23 Mar 2026 03:00 PM Biotechnology
Lowest Today 1.205
Highest Today 1.21
Today’s Open 1.205
Prev. Close 1.2
52 Week High 44.77
52 Week Low 1.14
Day’s Range: Low 1.205 High 1.21
52-Week Range: Low 1.14 High 44.77
1 day return -
1 Week return -2.41
1 month return -10.7
3 month return +40.97
6 month return -20.13
1 year return -59.53
3 year return -97.05
5 year return -99.98
10 year return -

Revelation Biosciences Inc Institutional Holdings

Sabby Management LLC 4.07

DRW Securities, LLC 0.52

Fidelity Extended Market Index 0.21

NT Ext Equity Mkt Idx Fd - L 0.13

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.05

Spartan Total Market Index Pool G 0.01

SBI Securities Co Ltd 0.00

Bank of America Corp 0.00

Armistice Capital, LLC 0.00

Citigroup Inc 0.00

Danske Bank A/S. 0.00

Jane Street Group LLC 0.00

Royal Bank of Canada 0.00

Tower Research Capital LLC 0.00

UBS Group AG 0.00

Revelation Biosciences Inc Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Revelation Biosciences Inc Fundamentals

Market Cap 4.43 M

PB Ratio 0.4996

PE Ratio 0.0

Enterprise Value -5.53 M

Total Assets 11582.92 M

Volume 33394

Revelation Biosciences Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:null 0.0M, FY19:95812000 95.8M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:90905000 90.9M

Annual Net worth FY23:875063 0.9M, FY22:-10794587 -10.8M, FY21:-11986837 -12.0M, FY20:-136408 -0.1M, FY19:31698000 31.7M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-6765 -0.0M, Q2/2025:-7220 -0.0M, Q1/2025:-7221 -0.0M, Q3/2024:null 0.0M, Q2/2024:-7220 -0.0M

Quarterly Net worth Q3/2025:-1907176 -1.9M, Q2/2025:-2444382 -2.4M, Q1/2025:-2051085 -2.1M, Q3/2024:-2241565 -2.2M, Q2/2024:-8389819 -8.4M

About Revelation Biosciences Inc & investment objective

Company Information Revelation Biosciences, Inc. operates as a clinical-stage life science company that focuses on the rebalancing inflammation to optimize health. The company's lead product candidate is lead product candidate Gemini, a proprietary formulation platform of phosphorylated hexaacyl disaccharide (PHAD), an established Toll-like receptor 4 (TLR) agonist that works by modulating and rebalancing a dysregulated inflammatory response. It also engages in the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.

Organisation Biotechnology

Employees 8

Industry Biotechnology

CEO Mr. James M. Rolke

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Revelation Biosciences Inc FAQs

What is the share price of Revelation Biosciences Inc today?

The current share price of Revelation Biosciences Inc is $1.23.

Can I buy Revelation Biosciences Inc shares in India?

Yes, Indian investors can buy Revelation Biosciences Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Revelation Biosciences Inc shares in India?

You can easily invest in Revelation Biosciences Inc shares from India by:

Can I buy fractional shares of Revelation Biosciences Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Revelation Biosciences Inc?

Revelation Biosciences Inc has a market cap of $4.43 M.

In which sector does Revelation Biosciences Inc belong?

Revelation Biosciences Inc operates in the Biotechnology sector.

What documents are required to invest in Revelation Biosciences Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Revelation Biosciences Inc?

The PE ratio of Revelation Biosciences Inc is N/A and the PB ratio is 0.50.